Ivan Ranđelović

433 total citations
28 papers, 326 citations indexed

About

Ivan Ranđelović is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ivan Ranđelović has authored 28 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Ivan Ranđelović's work include Chemical Synthesis and Analysis (5 papers), Peptidase Inhibition and Analysis (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ivan Ranđelović is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Peptidase Inhibition and Analysis (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ivan Ranđelović collaborates with scholars based in Hungary, Germany and Italy. Ivan Ranđelović's co-authors include József Tóvári, Gábor Mező, Beáta Biri‐Kovács, Ines Neundorf, Klaus Schomäcker, Gitta Schlosser, Sanja Mijatović, Bálint Szeder, Danijela Maksimović‐Ivanić and Goran N. Kaluđerović and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Ivan Ranđelović

27 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Ranđelović Hungary 12 192 135 88 44 38 28 326
Luca Monfregola Italy 13 223 1.2× 99 0.7× 107 1.2× 48 1.1× 55 1.4× 20 409
Ildikó Szabó Hungary 14 201 1.0× 122 0.9× 160 1.8× 29 0.7× 50 1.3× 28 406
Beatrice Stefanie Ludwig Germany 6 136 0.7× 89 0.7× 130 1.5× 32 0.7× 40 1.1× 9 347
Qingzhou Zhang China 13 329 1.7× 55 0.4× 184 2.1× 21 0.5× 43 1.1× 27 436
Jens Buchardt Denmark 11 341 1.8× 72 0.5× 169 1.9× 31 0.7× 15 0.4× 19 457
Allyson M. Freedy United States 7 252 1.3× 92 0.7× 129 1.5× 89 2.0× 18 0.5× 8 348
Patrick Gizzi France 11 162 0.8× 117 0.9× 77 0.9× 16 0.4× 29 0.8× 24 401
Rebecca L. Holden United States 9 222 1.2× 44 0.3× 36 0.4× 35 0.8× 28 0.7× 14 323
Gerard Artigas Spain 10 239 1.2× 120 0.9× 175 2.0× 65 1.5× 48 1.3× 12 374
Guy Mann Israel 11 399 2.1× 103 0.8× 210 2.4× 49 1.1× 9 0.2× 15 422

Countries citing papers authored by Ivan Ranđelović

Since Specialization
Citations

This map shows the geographic impact of Ivan Ranđelović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Ranđelović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Ranđelović more than expected).

Fields of papers citing papers by Ivan Ranđelović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Ranđelović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Ranđelović. The network helps show where Ivan Ranđelović may publish in the future.

Co-authorship network of co-authors of Ivan Ranđelović

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Ranđelović. A scholar is included among the top collaborators of Ivan Ranđelović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Ranđelović. Ivan Ranđelović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molnár, Eszter, Luca Hegedüs, Ivan Ranđelović, et al.. (2024). Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors. British Journal of Cancer. 130(6). 1059–1072. 15 indexed citations
2.
Cserepes, Mihály, et al.. (2024). Differential effects of hypoxia on motility using various in vitro models of lung adenocarcinoma. Scientific Reports. 14(1). 20482–20482.
3.
Mező, Gábor, Ivan Ranđelović, Eszter Lajkó, et al.. (2024). Oxime-Linked Peptide–Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview. International Journal of Molecular Sciences. 25(3). 1864–1864. 2 indexed citations
4.
Szabó, Ildikó, Beáta Biri‐Kovács, Ivan Ranđelović, et al.. (2024). Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH–Peptide Conjugates. International Journal of Molecular Sciences. 25(2). 1095–1095. 4 indexed citations
5.
Modena, Daniela, Ivan Ranđelović, Michela Bottani, et al.. (2024). In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy. European Journal of Medicinal Chemistry. 277. 116767–116767. 2 indexed citations
6.
Ranđelović, Ivan, Dušan Dimić, Danijela Maksimović‐Ivanić, et al.. (2024). (Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph2PCH2CH2SPh-κP,κS Ligand. Biomolecules. 14(4). 420–420. 5 indexed citations
7.
Ranđelović, Ivan, et al.. (2024). Targeting hypoxia in combination with paclitaxel to enhance therapeutic efficacy in breast and ovarian cancer. Biomedicine & Pharmacotherapy. 180. 117601–117601. 1 indexed citations
8.
Ranđelović, Ivan, Kinga Nyíri, József Tóvári, et al.. (2024). Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development. International Journal of Molecular Sciences. 25(5). 2572–2572. 5 indexed citations
9.
Biri‐Kovács, Beáta, et al.. (2023). Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates. International Journal of Molecular Sciences. 24(4). 3400–3400. 12 indexed citations
10.
Ranđelović, Ivan, et al.. (2023). Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker. Frontiers in Pharmacology. 14. 1215694–1215694. 3 indexed citations
11.
Ranđelović, Ivan, et al.. (2023). SREKA-targeted liposomes for highly metastatic breast cancer therapy. Drug Delivery. 30(1). 2174210–2174210. 5 indexed citations
12.
Ranđelović, Ivan, et al.. (2020). Effects of exercise programs on upper crossed syndrome: A systematic review. 7(2). 152–168. 4 indexed citations
13.
Ranđelović, Ivan, et al.. (2020). Efectos antiproliferativos <i>in vitro</i> y acciones antitumorales <i>in vivo</i> de la dafnetina en diferentes células tumorales. SHILAP Revista de lepidopterología. 88(6). 765–771. 7 indexed citations
14.
Rádai, Zita, Véronika Nagy, András Füredi, et al.. (2019). Synthesis and anticancer cytotoxicity with structural context of an α-hydroxyphosphonate based compound library derived from substituted benzaldehydes. New Journal of Chemistry. 43(35). 14028–14035. 16 indexed citations
15.
Ranđelović, Ivan, et al.. (2019). In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery. Pathology & Oncology Research. 26(3). 1879–1892. 27 indexed citations
16.
17.
Ranđelović, Ivan, et al.. (2019). Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice. International Journal of Molecular Sciences. 20(19). 4763–4763. 28 indexed citations
18.
Mező, Gábor, Gitta Schlosser, Eszter Lajkó, et al.. (2019). [Comparison of therapeutic peptides targeting pancreatic cancer].. PubMed. 63(4). 301–308. 1 indexed citations
19.
Ranđelović, Ivan, Danijela Maksimović‐Ivanić, Sanja Mijatović, et al.. (2014). Anticancer Potential of (Pentamethylcyclopentadienyl)chloridoiridium(III) Complexes Bearing κP and κP,κS‐Coordinated Ph2PCH2CH2CH2S(O)xPh (x=0–2) Ligands. ChemMedChem. 9(7). 1586–1593. 14 indexed citations
20.
Mijatović, Sanja, Ivan Ranđelović, Mirna Bulatović, et al.. (2013). Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph2PCH2S(O)xPh (x = 0–2) ligands. European Journal of Medicinal Chemistry. 69. 216–222. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Monfregola Breakdown of academic impact, for papers by Ildikó Szabó Breakdown of academic impact, for papers by Beatrice Stefanie Ludwig Breakdown of academic impact, for papers by Qingzhou Zhang Breakdown of academic impact, for papers by Jens Buchardt Breakdown of academic impact, for papers by Allyson M. Freedy Breakdown of academic impact, for papers by Patrick Gizzi Breakdown of academic impact, for papers by Rebecca L. Holden Breakdown of academic impact, for papers by Gerard Artigas Breakdown of academic impact, for papers by Guy Mann
Rankless by CCL
2026